Notice of Extra General Meeting 2020

The shareholders of Abera Bioscience AB, reg no 556909-0409, are hereby convened to the Extra General Meeting to be held the 2nd of December 2020 at 1 pm. Due to restriction because of Covid-19 the meeting will be held via video conference, see more information in the notice below.

Notice to the meeting (in Swedish):
Kallelse till extra bolagsstämma 2 dec 2020

Form for postal voting (in Swedish):
Formulär för poströstning

back to home page
back to news & events

contact us

Get in contact with us via the contact form or email: info@aberabio.com

Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane Bioscience.

NEws

  • © 2020 Abera Bioscience AB.​